FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,964,000 | -81.5% | 50,000 | -73.0% | 0.87% | -80.4% |
| Q2 2021 | $16,056,000 | +5.3% | 185,000 | 0.0% | 4.41% | +23.1% |
| Q1 2021 | $15,253,000 | +1.7% | 185,000 | +12.1% | 3.58% | +7.2% |
| Q4 2020 | $15,003,000 | +87.7% | 165,000 | -17.5% | 3.34% | +44.7% |
| Q3 2020 | $7,994,000 | +86.4% | 200,000 | +60.0% | 2.31% | +104.1% |
| Q2 2020 | $4,289,000 | -14.2% | 125,000 | -44.4% | 1.13% | -14.6% |
| Q1 2020 | $4,997,000 | -7.2% | 225,000 | -18.2% | 1.32% | +29.3% |
| Q4 2019 | $5,382,000 | -1.0% | 275,000 | -21.4% | 1.02% | -26.0% |
| Q3 2019 | $5,436,000 | +344.8% | 350,000 | +366.7% | 1.38% | +432.7% |
| Q3 2018 | $1,222,000 | +156.7% | 75,000 | -15.9% | 0.26% | +21.5% |
| Q3 2015 | $476,000 | – | 89,231 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |